26
Mar 2026
A copper-based agent complex kills cancer cells in a novel way. It receives its activation signal through light. It could help where existing chemotherapy treatments reach their limits.
26
Mar 2026
Integrating LLMs in brain tumor care could enhance patient understanding, but requires strict oversight to manage risks and ensure reliable information.
26
Mar 2026
The World Health Organization (WHO) reports a major shift in how countries are responding to the health needs of refugees and migrants, with new data showing more than 60 countries – two thirds of those surveyed – now include them in their national health policies and laws.
26
Mar 2026
Severe ankle pain drove Jelon Smart to start taking a weight loss injection a year and a half ago.
26
Mar 2026
Paternal mental health risks increase after childbirth, with delayed detection of psychiatric disorders underscoring the need for targeted support for fathers.
26
Mar 2026
Scott Deamer-Smith, Chief Technology Officer (CTO) at Bedfont® Scientific Limited, has been recognized for his outstanding contribution to innovation and technology.
26
Mar 2026
Spear Bio, an innovator in ultrasensitive protein biomarker detection, showcased three new SPEAR UltraDetect™ immunoassays—brain-derived p-Tau 217 (BD-pTau 217), α-synuclein (α-syn) and phospho-Ser129-α-synuclein (pS129-α-syn)—at the International Conference on Alzheimer’s & Parkinson’s Diseases (AD/PD 2026) last week.
26
Mar 2026
Chronic diseases including cancer, diabetes, neurocognitive disorders and infertility are rising globally, with health-harming products such as fossil fuels, tobacco, ultra‑processed foods, toxic chemicals, plastics and alcohol being major contributors, say the authors of a new paper published in New England Journal of Medicine (NEJM). The authors include proposed solutions, including policy safeguards and a stronger research focus on the risks to health connected with corporate activity.
_-_Illustration_-_Andrii_Vodolazhskyi_M1_4bb73c51d46c449285a21e8af28684d6-620x480.jpg "Microtubules unveiled as active enzyme regulators")
26
Mar 2026
Microtubules, the dynamic filaments that form the cell's internal scaffolding, have long been viewed as mere passive structural supports. But a new study reveals they play a far more active signaling role. The findings, published in Science Advances, demonstrate that microtubules are in fact regulators of enzymatic reactions through reshaping the geometry of the enzyme's substrate proteins attached to them and controlling when key events occur to conduct cell division.
26
Mar 2026
A team of researchers at Baylor College of Medicine, St. Jude Children's Research Hospital, Texas Children's Hospital, and collaborating institutions reveals in the journal Nature a novel mechanism that drives the development of pediatric supratentorial ependymoma (EPN), the third most common pediatric brain tumor. The findings suggest potential new approaches to treat these aggressive and chemo-resistant tumors.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
